STIMVIA

EUIPO EUIPO 2021 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark STIMVIA was filed as Word mark on 07/02/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/11/2021. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 018505497
Application date July 2, 2021
Publication date August 4, 2021
Entry date November 11, 2021
Expiration date July 2, 2031

Trademark owner

Sokola Tumy 1099/1
70900 Ostrava – Hulvaky
CZ

Trademark representatives

104 rue de Richelieu 75002 Paris FR

goods and services

9 Electrodes and devices for neurostimulation for scientific and research purposes; electrodes; pulse generators; downloadable computer software for use in the design and use of medical instruments and devices used in neuromodulation, electrostimulation or electroceuticals treatment and therapy
10 Medical apparatus and instruments; medical devices; electrodes for medical use; medical electrodes and medical devices for use in either of neuromodulation, electrostimulation or electroceuticals treatment and therapy; medical instruments and devices for use in either of electrostimulation, electroceuticals or neuromodulation treatment and therapy
42 Design, engineering, research, development and testing services for medical, scientific and technological applications; design and development of medical instruments and devices for use in neuromodulation, electrostimulation or electroceuticals treatment and therapy; technology research in the field of medical instruments and devices for use in neuromodulation, electrostimulation or electroceuticals treatment and therapy; medical and scientific research services; medical and scientific research in the fields of urology, neurology, gynecology, oncology, overactive bladder, neurodegenerative diseases, and chronic diseases using neuromodulation, electrostimulation or electroceuticals treatment and therapy; providing medical and scientific research information in the fields of urology, neurology, gynecology, oncology, neurodegenerative diseases and overactive bladder, and of chronic diseases using neuromodulation treatment and therapy; research and development of technology in the field of healthcare and medical devices; development of technology in the field of medical instruments and devices for neuromodulation electrostimulation or electroceuticals treatment and therapy; design and development of computer software; software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation, electrostimulation or electroceuticals treatment and therapy; providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in neuromodulation, electrostimulation or electroceuticals treatment and therapy
44 Medical services; healthcare services; medical services in the fields of urology, neurology, gynecology, oncology, neurodegenerative diseases, overactive bladder, and chronic diseases using electrostimulation, electroceuticals or neuromodulation treatment and therapy; medical consultancy; providing medical information in the fields of urology, neurology, gynecology, oncology, neurodegenerative diseases, overactive bladder, and chronic diseases using electrostimulation, electroceuticals or neuromodulation treatment and therapy; medical treatment of low urinary tract disfunction, Parkinson's diseases, Alzheimer's diseases, bowel disfunction, epilepsy, migraine and infertility using electrostimulation, electroceuticals or neuromodulation treatment or therapy; rental of medical instruments and devices for use in electrostimulation, electroceuticals or neuromodulation therapy

Trademark history

Date Document number Area Entry
August 5, 2024 Change Representative, Published
July 5, 2023 Change Representative, Published

ID: 11018505497